ES538675A0 - Formulacion de acido acetilsalicilico con efecto retardado - Google Patents

Formulacion de acido acetilsalicilico con efecto retardado

Info

Publication number
ES538675A0
ES538675A0 ES538675A ES538675A ES538675A0 ES 538675 A0 ES538675 A0 ES 538675A0 ES 538675 A ES538675 A ES 538675A ES 538675 A ES538675 A ES 538675A ES 538675 A0 ES538675 A0 ES 538675A0
Authority
ES
Spain
Prior art keywords
formulation
delayed effect
acetylsalicilic acid
acetylsalicilic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES538675A
Other languages
English (en)
Other versions
ES8605676A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8605676A1 publication Critical patent/ES8605676A1/es
Publication of ES538675A0 publication Critical patent/ES538675A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES538675A 1983-12-23 1984-12-17 Formulacion de acido acetilsalicilico con efecto retardado Expired ES8605676A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3346571A DE3346571A1 (de) 1983-12-23 1983-12-23 Oral retardierte acetylsalicylsaeureformulierungen

Publications (2)

Publication Number Publication Date
ES8605676A1 ES8605676A1 (es) 1986-04-01
ES538675A0 true ES538675A0 (es) 1986-04-01

Family

ID=6217790

Family Applications (1)

Application Number Title Priority Date Filing Date
ES538675A Expired ES8605676A1 (es) 1983-12-23 1984-12-17 Formulacion de acido acetilsalicilico con efecto retardado

Country Status (12)

Country Link
US (1) US4601895A (es)
EP (1) EP0146863A3 (es)
JP (1) JPS60152411A (es)
KR (1) KR850004393A (es)
AU (1) AU3658984A (es)
DE (1) DE3346571A1 (es)
ES (1) ES8605676A1 (es)
GR (1) GR82580B (es)
HU (1) HU191738B (es)
IL (1) IL73879A0 (es)
PT (1) PT79701A (es)
ZA (1) ZA8410045B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615027A (ja) * 1984-06-18 1986-01-10 Sadahiro Nakano 徐放性固形製剤
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
US4855139A (en) * 1987-01-20 1989-08-08 Med. Fab (Lafayette), Inc. Fungicidally active cellulosic textile compositions, or articles of manufacture
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
ZA942818B (en) * 1993-04-23 1995-01-30 Bio Technology General Corp Method of enhancing thrombolysis.
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
WO1997002019A1 (en) 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials
JP4064476B2 (ja) * 1996-03-29 2008-03-19 エラワン ファーマスーティカル リサーチ アンドラボラトリー カンパニー リミテッド 二酸化珪素を有する球状凝集した澱粉
IN186245B (es) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6852337B2 (en) * 1998-04-09 2005-02-08 Roche Diagnostics Gmbh Carvedilol-galenics
US20080132456A1 (en) * 2004-12-09 2008-06-05 Ragnar Ek Pharmaceutical Formulation Comprising Low Crystallinity Cellulose

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE737909C (de) * 1940-11-19 1943-07-29 Apothekerschaft Deutsche Verfahren zur Beseitigung des Wasseranziehungsvermoegens und zur geschmacklichen Verbesserung arzneilich verwendbarer Stoffe
US3034911A (en) * 1959-03-25 1962-05-15 Nat Starch Chem Corp Tablet disintegrants
FR280067A (es) * 1960-11-17
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US3725556A (en) * 1970-11-12 1973-04-03 D Hanssen Method of manufacturing rapidly disintegrating pharmaceutical tablets
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4328217A (en) * 1972-12-29 1982-05-04 Mead Johnson & Company Bran tablet composition and process
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4086335A (en) * 1975-10-29 1978-04-25 Bruscato Frank N Pharmaceutical tablets containing chitin as a disintegrant
DE2708513C3 (de) * 1977-02-26 1981-01-08 C.H. Boehringer Sohn, 6507 Ingelheim Wasserunlösliche, physiologisch unbedenkliche Masse, Verfahren zu ihrer Herstellung und ihre Verwendung
US4198507A (en) * 1978-11-13 1980-04-15 Hoffmann-La Roche Inc. Theophylline magnesium salicylate
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
US4401665A (en) * 1981-04-14 1983-08-30 Bristol-Myers Company Sleep-aid composition containing an analgesic and diphenhydramine dihydrogencitrate, and method of use
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4390545A (en) * 1981-11-19 1983-06-28 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
US4525345A (en) * 1981-12-24 1985-06-25 Verex Laboratories, Inc. Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
US4539198A (en) * 1983-07-07 1985-09-03 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules

Also Published As

Publication number Publication date
PT79701A (en) 1985-01-01
HU191738B (en) 1987-04-28
JPS60152411A (ja) 1985-08-10
DE3346571A1 (de) 1985-07-04
EP0146863A3 (de) 1986-10-08
ES8605676A1 (es) 1986-04-01
AU3658984A (en) 1985-06-27
ZA8410045B (en) 1985-08-28
GR82580B (en) 1985-04-23
IL73879A0 (en) 1985-03-31
KR850004393A (ko) 1985-07-15
HUT36704A (en) 1985-10-28
EP0146863A2 (de) 1985-07-03
US4601895A (en) 1986-07-22

Similar Documents

Publication Publication Date Title
ES536502A0 (es) Procedimiento para la fabricacion de acido 7beta-(carboxialquenoilamino)-3-cefem-4-carboxilico
NL930128I1 (nl) Bereiding van erythropoietine
ES532472A0 (es) Procedimiento de producir acido n-fosfonometilglicinico
AR231431A1 (es) Derivados de acido perhaloalquilvinilociclopropancarboxilico con propiedades insecticidas
ES538675A0 (es) Formulacion de acido acetilsalicilico con efecto retardado
IT1150198B (it) Derivato di acido chinolincarbossilico
NO842526L (no) Fremgangsmaate for fremstilling av salpetersyreestere
MX161562A (es) Procedimiento para producir acido acrilico
IT8149999A0 (it) Preparazione di anidridi di acido carbossilico
FI840138A0 (fi) Detergentblandning i partikelform
ES538263A0 (es) Procedimiento para la preparacion de cianamidas de acido 2-fenoxi-propionico
TR22146A (tr) Difloropiridin bilesiklerinin hazirlanmasi
ES535000A0 (es) Procedimiento para la preparacion de derivados de acido piridacinilcarboxilico
ES540037A0 (es) Procedimiento para la obtencion de derivados de acido barbi-turico
GB8413890D0 (en) Preparation of square acid
NO845148L (no) Fremgangsmaate for fremstilling av 16-fenoksy- og 16-substituert-fenoksy-prostatrinsyre-derivater
IT8349068A0 (it) Preparazione di anidridi di acido carbossilico
ES545805A0 (es) Procedimiento para la preparacion de esteres de acido guani-dinobenzoico
LT2254B (lt) 1-etoksikarboniloksietilo esterio 6-(d-(-)-2-amino2-fenilacetamido)-penicilano rugsties druskos su halogenvandeniline rugstimi gavimo budas
ES535896A0 (es) Procedimiento para preparar poliesteres de acido bencilidenmalonico
IT1200125B (it) Composti di cefalosporina e procedimento per produrli
DE3361290D1 (de) Preparation of cyanobenzoic-acid esters
IT1163145B (it) Preparazione di acido benzoico puro
ES537987A0 (es) Procedimiento para la fabricacion de acido 4-nitrotoluen-2-sulfonico
IT1206155B (it) Preparazione di acido acetico